|
|
|
|
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Release Teva Announces Approval Of Fludarabine Phosphate Injection Jerusalem, Israel, April 29, 2004 - Teva Pharmaceutical Industries Ltd.
Food and Drug Administration has granted approval for an ANDA for Fludarabine Phosphate Injection, 25 mg/ml, which was submitted by the Company’s subsidiary Sicor Inc.
Shipment of...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL I.V., METRONIDAZOLE HYDROCHLORIDE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HCL, FLAVOXATE HYDROCHLORIDE FLAXEDIL, GALLAMINE TRIETHIODIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLEXICORT, HYDROCORTISONE FLOLAN, EPOPROSTENOL SODIUM...
|
|
|
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
|
|
|
rld_labeling_approved_may_1999
Firm Date ISUPREL Isoproterenol Hydrochloride Injection 10-515 S-022 Abbott 4-May-1999 PATINOL /PLATINOL-AQ Cisplatin For Injection/Cisplatin Injection 18-057 S-068 Bristol Myers Squibb 5-May-1999 MAXAQUIN Lomefolxacin Hydrochloride 20-013 S-013 Searle 6-May-1999 URACIL MUSTARD Uracil Mustard capsules 12-892 S-001 Roberts Labs 6-May-1999 ESTROSTEP Norethindrone acetate/ethinyl...
|
|
|
FDA Drug Approvals List December 2001
Active Ingredient(s): LISINOPRIL OTC/RX Status: RX Original Abbreviated Application #: 076058 Tentative Approval Date: 21-DEC-01 Trade Name: MIDAZOLAM HCL Dosage Form: SYRUP Applicant: RANBAXY LABORATORIES LTD Active Ingredient(s): MIDAZOLAM HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Application #: 076134 Tentative Approval Date: 20-DEC-01 Trade Name: LORATADINE Dosage Form...
|
|
|
http://www.fda.gov/cder/da/ddpa91.wpd
DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER APPROVAL DATE (CLASSIFICATION)TRADE NAME (DOSAGE FORM)APPLICANTACTIVE INGREDIENT(S) STRENGTH(S) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 20 057 CEREDASE GENZYME ALGLUCERASE 04 05-91 (INJECTABLE) BOSTON, MA 80 UNITS/ML (1 A, V*) 02111 (BETA-GLUCOCEREBROSIDASE ENZYME...
|
|
|
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
|
|
|
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
|
|
|
Welcome to Genta Incorporated
- - Genasense ® is a drug that inhibits the production of a protein known as Bcl-2.
This process is known as programmed cell death or apoptosis.
Genta's clinical trials programs focus on pretreating cancer patients with Genasense prior to the administration of anticancer therapy with the intention of potentiating the cancer-killing effects of treatment.
Genta is...
|
